Indication: Breast Cancer

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

Neoadjuvant Chemo

Sub-indication: Post neoadjuvant chemotherapy radiation - postive axillary nodes before neoadjuvant chemo converting to path negative axillary nodes after neoadjuvant chemo

Line of Therapy: Post neoadjuvant chemotherapy radiation- with positive axillary nodes before neoadjuvant chemo converting to path negative axillary nodes after neoadjuvant chemo

Drug Study

Principal Investigator: Mark Cornett, M.D.
Norton Cancer Institute

Sponsor: National Surgical Adjuvant Breast and Bowel Project (NSABP)

Learn more at ClinicalTrials.gov

Email for more information: Breast-NCIResearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.